Recently, the 23rd CPHI China 2025 grandly opened at the Shanghai New International Expo Center. Xu Hua, Vice President of Tianjin Pharmaceuticals Group and Party Secretary and Chairman of Tianjin Pharma, along with Li Shuxiang, Deputy Party Secretary and General Manager of Tianjin Pharma, led the delegation to showcase the company's comprehensive strength.

At the exhibition, Tianjin Pharma meticulously arranged three booths, showcasing its full range of products including active pharmaceutical ingredients (APIs) and finished dosage forms. Over 400 new and existing clients from multiple countries and regions worldwide visited the booths, engaging in in-depth discussions with the Jinyao team on product portfolios, technological innovation, and market collaboration. These interactions injected new momentum into the company's efforts to deepen global partnerships and drive high-quality business development.

Aligned with the company's strategic development, three distinct divisions operate with precise positioning and clear responsibilities. The API Sales Department fully demonstrated the company's international standing and brand influence in active pharmaceutical ingredients. The Formulation Sales Department explored internationalization pathways for pharmaceutical preparations with numerous partners, focusing efforts on the Belt and Road Initiative. Hubei Tianjin Pharma engaged in in-depth discussions with domestic and international clients to define the international positioning of its injectable products and commence planning for the 15th Five-Year Plan.